Impact of Covid-19 on Pharmaceutical Companies

There is no one in the whole world who is not aware of the minute monster, the coronavirus. This virus is known to originate in the city of Wuhan, China and has given rise to the disease called COVID-19 which became a global pandemic.

Covid 19 has affected the complete economy of not only India, but of the whole world. Among all, the major effect was observed on the health market mainly the pharmaceutical sector. The Indian pharmaceutical industry is the world’s third largest drug producer and during these struggling times, all the pharmaceutical companies are playing key role to cope up with the situation. Amster Labs is a Third Party Pharmaceutical Manufacturer in India, 3rd Party Manufacturing Pharmaceuticals in India which is also deeply involved in coping with the covid situation. As our nation has to face the low availability of drugs during this pandemic, Amster Labs, being the Pharmaceutical Contract Manufacturing Company in India, is participating in maintenance of the natural market flow of medicines and is supplying essential Pharma products at an affordable price.

Though the whole world is busy in finding the treatment, currently no assured option is available for this novel infectious disease. All the pharmaceutical industries are standing at the front to help government in addressing the COVID-19 unmet needs by their efforts ranging from research and development actions on potential treatment strategies to maintaining balance in the medicines supply chain in the time of crisis. Amster Labs is the Pharmaceutical Franchise Company in Baddi Himachal Pradesh, and is also doing well in the R&D processes in order to find a vaccine against the coronavirus. The pharmaceutical scientists at Amster Labs are well educated and trained to discover, develop, and manufacture new medications.

During this pandemic time, the economy of the whole world is disturbed, but the pharmaceutical companies are believed to have positive growth on the stock market. On the dark side of the image, the coronavirus outbreak has even hit the pharmaceutical sector by rising the prices of key ingredients. The active pharmaceutical ingredients (API) and basic chemicals used to manufacture Covid drugs have skyrocketed during this pandemic because of opportunistic pricing, black marketing, short supply and weakening of the rupee. Though the Indian pharma sector is an important component of the global healthcare infrastructure and is involved in saving millions of lives every year, it is also facing worse situation during this struggling time. This problem can be linked with the reason that India has been importing most of the raw materials from China, the epicentre of the outbreak.

Generic drugs produced by Indian drug manufacturers are usually used worldwide. If we look at the demand rate, a high demand of such drugs has led to shortages at the pharmacy counter. Amster Labs, the Top Pharmaceutical Manufacturer Company in India also manufactures generic drugs which play crucial role in the fight against COVID–19 infections. Therefore, this company is working round the clock to keep a continuous supply of these medicines to the consumers.